Ovarian Cancer Canada | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

98,887 results for “Ovarian Cancer Canada”

Canadian Patients and Advocacy Groups Escalate Pressure to Fund Ovarian Cancer Drug Elahere After Negotiations Collapse

Molecular Testing Advances Personalized Treatment Strategies in Ovarian Cancer

Intensive Chemo Shows Promise in Relapsed Ovarian Cancer

FDA Grants Full Approval to Elahere for Platinum-Resistant Ovarian Cancer

HIPEC Plus Surgery Improves Survival in Recurrent Ovarian Cancer

Repurposed HIV Drug Shows Promise in Treatment-Resistant Ovarian Cancer

Tesaro's Niraparib Approved for Ovarian Cancer Maintenance Therapy

Targeted Therapies Show Promise in High-Grade Serous Ovarian Cancer Treatment

MRI-Based Imaging Predicts Chemotherapy Response in Ovarian Cancer Within 48 Hours

Health Canada Approves Expansion of Decoy20 Cancer Immunotherapy Trial

Page 1 of 1596